Medical Stop Loss
We offer flexible specific and aggregate coverage, insurance, reinsurance, risk share, and underwriting-only stop loss solutions
Complete array of coverage options for both large and small self-funded groups
Specific
Coverage per individual participant limits high-cost claimant exposure
Available medical-only, or medical with Rx
Aggregate
Coverage for entire group limits overall claims costs
Can include medical-only or a combination of medical with Rx, dental, and vision
Reinsurance
We offer multiple stop loss reinsurance arrangements to help you manage – and mitigate – risk
Gene Therapy
Solutions to manage the high costs of gene therapies
Cost Containment Solutions
Access to a variety of partnerships with specialty vendors and service providers that support clinical intervention and cost-saving initiatives to manage exposure to high-cost claims
BCS Stop Loss customers have access to BCS RiskNavigator and cost containment solutions.
-
Now Quoting Gene Therapy Stop Loss for 2026
Understanding Gene Therapy Stop LossGene therapies offer the promise of potential cures for disease and genetic disorders, yet come at unprecedented costs ($2M to $4M per treatment). Self-funded employers are exposed to both frequency and severity of these catastrophic $2-4M claims. That’s why BCS has developed gene therapy stop loss products, known as Stop Loss…